Generic Biaxin is in a group of drugs called macrolide antibiotics. It is used to treat many different types of bacterial infections affecting the skin and respiratory system. It is also used together with other medicines to treat stomach ulcers caused by Helicobacter pylori. More info »
I have received all of my order plus the bonus pills. You not only met my
expectations but greatly exceeded them!
You properly set my expectations by providing me all the information that I would
need during the ordering process and then followed up regularly to insure that all
was occurring as it should.
Your focus on customer service is outstanding and has won me over as a long time
customer. I have already recommended you to two of my friends and will continue to
do so in the future. I am also very pleased with the quality of your product and
accompanying reference materials that I received with my order.
I will do all of my medical business through your firm from this point forward.
Thank you for your proactive efforts and strong customer focused business
practices. I can honestly say my purchase experience has been outstanding!
- Sincerely, Lloyd
Pernix Therapeutics Introduces Omeclamox-PakĀ®, First Product in ... - MarketWatch (press release)
Pernix Therapeutics Introduces Omeclamox-PakĀ®, First Product in .
FDA to Review CV Risk With Azithromycin - Medscape
FDA to Review CV Risk With AzithromycinMedscapeThat class, called macrolides, also includes clarithromycin (Biaxin, Abbott) and erythromycin, neither of which figured into the NEJM study.
Zithromax and the Risk of Cardiovascular Death - Kansas City infoZine
Zithromax and the Risk of Cardiovascular DeathKansas City infoZineThe drug labels for clarithromycin and erythromycin also contain information about QT interval prolongation in the WARNINGS section.
Fighting Back Against Lyme Disease - Huffington Post
Fighting Back Against Lyme DiseaseHuffington PostFood enhances absorption of cefuroxime and of the extended-release form of clarithromycin.
Pernix launches new therapy to eradicate H. pylori - Pharmaceutical Business Review